Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 89, Issue 5, Pages 646-647Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/clpt.2010.308
Keywords
-
Categories
Ask authors/readers for more resources
The ability to generate human induced pluripotent stem (iPS) cells presents exciting prospects for drug discovery and the development of safer, more effective drugs. Given the enormous potential for iPS cell-based drug development, what ethical issues could possibly cloud this new biomedical horizon?
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
